SCHEMBL186687

SCHEMBL186687

CC(C)CCCCCCCCCCCCCCCOCC(O)CO

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.67
HTT P42858 1/20 0.46
PLA2G2C Q5R387 2/20 0.43
LPAR5 Q9H1C0 1/20 0.40
SPHK1 Q9NYA1 2/20 0.39
HSD17B10 Q99714 1/20 0.38
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
LMNA P02545 3/20 0.35
KDM4E B2RXH2 1/20 0.35
DUSP3 P51452 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SPHK2 Q9NRA0 1/20 0.35
AGTR1 P30556 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL116776 1.00 USP2 (0.67) USP2HTTPLA2G2CLPAR5SPHK1
SCHEMBL28398602 1.00 USP2 (0.67) USP2HTTPLA2G2CLPAR5SPHK1
SCHEMBL11196687 1.00 USP2 (0.67) USP2HTTPLA2G2CLPAR5SPHK1
SCHEMBL10596495 1.00 USP2 (0.67) USP2HTTPLA2G2CLPAR5SPHK1
SCHEMBL1505222 1.00 USP2 (0.67) USP2HTTPLA2G2CLPAR5SPHK1
SCHEMBL25200006 1.00 USP2 (0.67) USP2HTTPLA2G2CLPAR5SPHK1
SCHEMBL9352436 0.98 USP2 (0.65) USP2HTTPLA2G2CLPAR5SPHK1
SCHEMBL15418147 0.96 USP2 (0.62) USP2HTTPLA2G2CLPAR5SPHK1
SCHEMBL9813386 0.96 USP2 (0.62) USP2HTTPLA2G2CLPAR5SPHK1
SCHEMBL118299 0.92 USP2 (0.60) USP2HTTPLA2G2CLPAR5SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1565 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250241867-A1 HYDROGEL PATCH COMPOSITION USING ARNICA FERMENTED EXTRACT WOOSHIN LABOTTACH CO., LTD. (KR) 2025-07-31 US claimed
EP-4021379-B1 COMPOSITION, PROCESS AND KIT FOR SEMI-PERMANENT STRAIGHTENING AND CURLING OF KERATIN FIBERS KAO CORP (JP) 2025-06-18 EP claimed
CN-114340593-B Compositions, methods and kits for semi-permanent straightening and crimping of keratin fibers 花王株式会社 2025-05-06 CN claimed
CN-119345056-A Instant red-dispelling composition, application thereof, cosmetic composition and preparation method thereof 上海菲珂尔化妆品有限公司 2025-01-24 CN claimed
CN-117881390-B Emulsifying composition 花王株式会社 2024-12-13 CN claimed
CN-114099357-B Polyol-in-oil nanoemulsion containing hydroxytyrosol and preparation method and application thereof 江苏瑞霆生物科技有限公司 2024-09-20 CN claimed
CN-111615381-B Pharmaceutical composition for transdermal administration in the form of a hydrogel patch 大化制药株式会社 2024-02-23 CN claimed
US-11786448-B2 Cosmetic composition for improved bleaching or dyeing of keratin fibers KAO CORPORATION (JP) 2023-10-17 US claimed
CN-113811364-B Hair treatment method 花王株式会社 2023-09-05 CN claimed
WO-2023058469-A1 COSMETIC COMPOSITION 株式会社 資生堂 2023-04-13 WO claimed
US-8795421-B2 W/O emulsion ink for inkjet RISO KAGAKU CORPORATION (JP) 2014-08-05 US claimed
US-8486379-B2 Lip cosmetics SHISEIDO COMPANY, LTD. (JP) 2013-07-16 US claimed
EP-2589372-A1 LIP COSMETIC Shiseido Company, Limited (JP) 2013-05-08 EP claimed
US-20130101539-A1 Lip Cosmetics SHISEIDO COMPANY, LTD. (JP) 2013-04-25 US claimed
WO-2012105715-A1 NOVEL EXTERNAL PREPARATION DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-08-09 WO claimed
US-20110282103-A1 PROCESS FOR THE PREPARATION OF POLYGLYCERYL ETHER DERIVATIVES KAO CORPORATION (JP) 2011-11-17 US claimed
US-7481996-B2 Aerosol cosmetic composition KAO CORPORATION (JP) 2009-01-27 US claimed
US-20080188395-A1 CLEANSING COMPOSITION KAO CORPORATION (JP) 2008-08-07 US claimed
EP-1952795-A2 Cleansing composition KAO CORPORATION (JP) 2008-08-06 EP claimed
US-6849576-B2 Plant-activating agent KAO CORPORATION (JP) 2005-02-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110282103-A1 PROCESS FOR THE PREPARATION OF POLYGLYCERYL ETHER DERIVATIVES AGL, AGPAT2, GK USP2 3180/4885HTT 3253/4885PLA2G2C 267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.